Estudo da produção do radiofármaco FLT-18F em sistema automatizado: contribuição para a avaliação do processo

Estudo da produção do radiofármaco FLT-18F em sistema automatizado: contribuição para a avaliação do processo

O radiofármaco FLT-18F é um análogo do nucleosídeo timidina e um promissor marcador da proliferação tumoral para imagens em PET. A síntese deste radiofármaco não é simples e, muitas vezes, apresenta baixos rendimentos. Este radiofármaco já vem sendo estudado há alguns anos, porém, não há produção, n...

Full description

Bibliographic Details
Main Author:	Zanette, Camila
Other Authors:	Araújo, Elaine Bortoleti de
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2013
Subjects:	Boas Práticas de Fabricação FLT Good Manufacturing Practice radiofármaco radiopharmaceutical
Online Access:	http://www.teses.usp.br/teses/disponiveis/85/85131/tde-04072013-140325/

Similar Items

Estudo da produção do radiofármaco FLT-18F em sistema automatizado: contribuição para a avaliação do processo
by: Camila Zanette
Published: (2013)

Estudo da produção do radiofármaco FLT-18F em sistema automatizado: contribuição para a validação do processo
by: ZANETTE, CAMILA
Published: (2013)

Estudo da produção do radiofármaco FLT-18F em sistema automatizado: contribuição para a validação do processo
by: ZANETTE, CAMILA
Published: (2013)

Estudo, desenvolvimento e construção de célula multipropósito para produção de radiofármacos, em acordo com parâmetros e padrões de Boas Práticas de Fabricação (BPF)
by: Campos, Fábio Eduardo de
Published: (2018)

Estudo, desenvolvimento e construção de célula multipropósito para produção de radiofármacos, em acordo com parâmetros e padrões de Boas Práticas de Fabricação (BPF)
by: Fábio Eduardo de Campos
Published: (2018)

Toxicidade aguda e subaguda do radiofármaco 18F-FDG
by: Danielle Maia Dantas
Published: (2013)

Toxicidade aguda e subaguda do radiofármaco 18F-FDG
by: Dantas, Danielle Maia
Published: (2013)

The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
by: Francisco J. Cueto, et al.
Published: (2021-03-01)

Estudo do efeito da associação do ácido all-trans retinoico (ATRA) com inibidores do FLT3 em modelos de leucemia mieloide aguda com mutações internas em tandem no gene FLT3
by: Mendoza, Silvia Elena Sanchez
Published: (2019)

Discovery of 5-methyl-N-(2-arylquinazolin-7-yl)isoxazole-4-carboxamide analogues as highly selective FLT3 inhibitors
by: Daseul Im, et al.
Published: (2020-01-01)

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
by: Vanessa E. Kennedy, et al.
Published: (2020-12-01)

The biology and targeting of FLT3 in pediatric leukemia
by: Colleen eAnnesley, et al.
Published: (2014-09-01)

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype
by: Irina Stepanovna Martynkevich, et al.
Published: (2010-12-01)

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
by: Juanjuan Zhao, et al.
Published: (2019-09-01)

First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations
by: Naval Daver, et al.
Published: (2020-08-01)

FLT3 Gene Mutation in Acute Myeloid Leukemia: Correlation with Hematological, Immunophenotypic, and Cytogenetic Characteristics
by: Sunitha Shankaralingappa, et al.
Published: (2021-06-01)

Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients
by: EK Zaikova, et al.
Published: (2019-03-01)

Determinação de endotoxina bacteriana (pirogênio) em radiofármacos pelo método de formação de gel. Validação
by: Neuza Taeko Okasaki Fukumori
Published: (2008)

Determinação de endotoxina bacteriana (pirogênio) em radiofármacos pelo método de formação de gel. Validação
by: Fukumori, Neuza Taeko Okasaki
Published: (2008)

Polymorphisms in the Flt1 gene and their relation to expression of the secreted Flt1 variant
by: Ajlouni, Burouj Kayed
Published: (2014)

Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML
by: Musa Yilmaz, et al.
Published: (2020-10-01)

Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling
by: Ying Xu, et al.
Published: (2021-01-01)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of <i>FLT3</i>-Mutated AML
by: Stephen S.Y. Lam, et al.
Published: (2020-02-01)

FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia
by: Mariko Takenokuchi, et al.
Published: (2012-10-01)

Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
by: Sebastian Scholl, et al.
Published: (2020-11-01)

FLT3 inhibitors: clinical potential in acute myeloid leukemia
by: Hospital MA, et al.
Published: (2017-02-01)

Síntese, controle de qualidade e ensaios de eficácia e toxicidade in vitro do radiofármaco 18F Fluortimidina (18FLT)
by: Leonardo Tafas Constantino do Nascimento
Published: (2014)

FLT3/FLT3L-mediated CD103+ dendritic cells alleviates hepatic ischemia-reperfusion injury in mice via activation of treg cells
by: Chun-ze Zhou, et al.
Published: (2019-10-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series
by: Ahmad S. Alotaibi, et al.
Published: (2020-10-01)

Estudo de demanda do radiofármaco 18F-FDG nas regiões metropolitanas de São Paulo e áreas adjacentes
by: Renato Cesar Sato
Published: (2006)

Estudo de demanda do radiofármaco 18F-FDG nas regiões metropolitanas de São Paulo e áreas adjacentes
by: Sato, Renato Cesar
Published: (2006)

Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
by: Pierre Lovinfosse, et al.
Published: (2019-12-01)

Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis
by: Monica Hellesøy, et al.
Published: (2021-09-01)

Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
by: Ying Wang, et al.
Published: (2018-05-01)

Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns
by: Wei Guan, et al.
Published: (2021-04-01)

Role of the Intron 13 Polypyrimidine Tract in Soluble Flt-1 Expression
by: Roche, Rebecca I.
Published: (2014)

Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis
by: Takashi Norikane, et al.
Published: (2017-08-01)

Functions of Novel Ligand-independent Flt3 Alleles and RANKL in Promoting Dissemination of Murine B-Cell Leukemias to the Central Nervous System
by: Papp, Eniko
Published: (2013)

Functions of Novel Ligand-independent Flt3 Alleles and RANKL in Promoting Dissemination of Murine B-Cell Leukemias to the Central Nervous System
by: Papp, Eniko
Published: (2013)